Armen A Ghazarian1, Britton Trabert1, Barry I Graubard1, Stephen M Schwartz2,3, Sean F Altekruse4, Katherine A McGlynn1. 1. Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, Maryland. 2. Epidemiology Program, Public Health Science Division, Fred Hutchinson Cancer Research Center, Seattle, Washington. 3. Department of Epidemiology, School of Public Health, University of Washington, Seattle, Washington. 4. Division of Cancer Control and Population Sciences, National Cancer Institute, Bethesda, Maryland.
Abstract
BACKGROUND: The incidence of testicular germ cell tumors (TGCTs) in the United States is notably higher among white men versus other men. Previously, however, it was reported that rates were rising among Hispanics in certain areas. To determine whether this finding was evident in a wider area of the United States, data from 39 US cancer registries were examined. METHODS: Racial/ethnic-specific incidence rates per 100,000 man-years were calculated overall and by census region for the period of 1998-2011. Annual percentage changes (APCs) were estimated, and joinpoint models were fit. Differences in incidence by region were examined with the Wald test. RESULTS: From 1998 to 2011, 88,993 TGCTs were recorded. The TGCT incidence was highest among non-Hispanic whites (6.57 per 100,000), who were followed by Hispanics (3.88), American Indians/Alaska Natives (2.88), Asians/Pacific Islanders (A/PIs; 1.60), and non-Hispanic blacks (1.20). The incidence significantly increased among Hispanics (APC, 2.31; P < .0001), with rates rising in all regions except the South. Rates rose slightly among non-Hispanic whites (APC, 0.51; P = .0076). Significant differences in rates by region were seen for Hispanics (P = .0001), non-Hispanic whites (P < .0001), and A/PIs (P < .0001), with the highest rates among Hispanics in the West and with the highest rates among non-Hispanic whites and A/PIs in the Northeast. CONCLUSIONS: Although the incidence of TGCTs remained highest among non-Hispanic whites between 1998 and 2011, the greatest increase was experienced by Hispanics. Rising rates of TGCTs among Hispanics in the United States suggest that future attention is warranted. Reasons for the increase may include variability in birthplace, changing exposures, genetic susceptibility, and the length of US residence.
BACKGROUND: The incidence of testicular germ cell tumors (TGCTs) in the United States is notably higher among white men versus other men. Previously, however, it was reported that rates were rising among Hispanics in certain areas. To determine whether this finding was evident in a wider area of the United States, data from 39 US cancer registries were examined. METHODS: Racial/ethnic-specific incidence rates per 100,000 man-years were calculated overall and by census region for the period of 1998-2011. Annual percentage changes (APCs) were estimated, and joinpoint models were fit. Differences in incidence by region were examined with the Wald test. RESULTS: From 1998 to 2011, 88,993 TGCTs were recorded. The TGCT incidence was highest among non-Hispanic whites (6.57 per 100,000), who were followed by Hispanics (3.88), American Indians/Alaska Natives (2.88), Asians/Pacific Islanders (A/PIs; 1.60), and non-Hispanic blacks (1.20). The incidence significantly increased among Hispanics (APC, 2.31; P < .0001), with rates rising in all regions except the South. Rates rose slightly among non-Hispanic whites (APC, 0.51; P = .0076). Significant differences in rates by region were seen for Hispanics (P = .0001), non-Hispanic whites (P < .0001), and A/PIs (P < .0001), with the highest rates among Hispanics in the West and with the highest rates among non-Hispanic whites and A/PIs in the Northeast. CONCLUSIONS: Although the incidence of TGCTs remained highest among non-Hispanic whites between 1998 and 2011, the greatest increase was experienced by Hispanics. Rising rates of TGCTs among Hispanics in the United States suggest that future attention is warranted. Reasons for the increase may include variability in birthplace, changing exposures, genetic susceptibility, and the length of US residence.
Keywords:
North American Association of Central Cancer Registries (NAACCR); ethnic groups; incidence; testicular cancer; testicular germ cell tumor (TGCT); trends
Authors: Peter A Kanetsky; Nandita Mitra; Saran Vardhanabhuti; Mingyao Li; David J Vaughn; Richard Letrero; Stephanie L Ciosek; David R Doody; Lauren M Smith; Joellen Weaver; Anthony Albano; Chu Chen; Jacqueline R Starr; Daniel J Rader; Andrew K Godwin; Muredach P Reilly; Hakon Hakonarson; Stephen M Schwartz; Katherine L Nathanson Journal: Nat Genet Date: 2009-05-31 Impact factor: 38.330
Authors: Clare Turnbull; Elizabeth A Rapley; Sheila Seal; David Pernet; Anthony Renwick; Deborah Hughes; Michelle Ricketts; Rachel Linger; Jeremie Nsengimana; Panagiotis Deloukas; Robert A Huddart; D Timothy Bishop; Douglas F Easton; Michael R Stratton; Nazneen Rahman Journal: Nat Genet Date: 2010-06-13 Impact factor: 38.330
Authors: Elizabeth A Rapley; Clare Turnbull; Ali Amin Al Olama; Emmanouil T Dermitzakis; Rachel Linger; Robert A Huddart; Anthony Renwick; Deborah Hughes; Sarah Hines; Sheila Seal; Jonathan Morrison; Jeremie Nsengimana; Panagiotis Deloukas; Nazneen Rahman; D Timothy Bishop; Douglas F Easton; Michael R Stratton Journal: Nat Genet Date: 2009-05-31 Impact factor: 38.330
Authors: Goncalo R Abecasis; Adam Auton; Lisa D Brooks; Mark A DePristo; Richard M Durbin; Robert E Handsaker; Hyun Min Kang; Gabor T Marth; Gil A McVean Journal: Nature Date: 2012-11-01 Impact factor: 49.962
Authors: Charles C Chung; Peter A Kanetsky; Zhaoming Wang; Michelle A T Hildebrandt; Roelof Koster; Rolf I Skotheim; Christian P Kratz; Clare Turnbull; Victoria K Cortessis; Anne C Bakken; D Timothy Bishop; Michael B Cook; R Loren Erickson; Sophie D Fosså; Kevin B Jacobs; Larissa A Korde; Sigrid M Kraggerud; Ragnhild A Lothe; Jennifer T Loud; Nazneen Rahman; Eila C Skinner; Duncan C Thomas; Xifeng Wu; Meredith Yeager; Fredrick R Schumacher; Mark H Greene; Stephen M Schwartz; Katherine A McGlynn; Stephen J Chanock; Katherine L Nathanson Journal: Nat Genet Date: 2013-05-12 Impact factor: 38.330
Authors: Armen A Ghazarian; Scott P Kelly; Sean F Altekruse; Philip S Rosenberg; Katherine A McGlynn Journal: Cancer Date: 2017-02-27 Impact factor: 6.860
Authors: Ali H Mokdad; Laura Dwyer-Lindgren; Christina Fitzmaurice; Rebecca W Stubbs; Amelia Bertozzi-Villa; Chloe Morozoff; Raghid Charara; Christine Allen; Mohsen Naghavi; Christopher J L Murray Journal: JAMA Date: 2017-01-24 Impact factor: 56.272
Authors: Armen A Ghazarian; Britton Trabert; Barry I Graubard; Matthew P Longnecker; Mark A Klebanoff; Katherine A McGlynn Journal: Am J Epidemiol Date: 2018-07-01 Impact factor: 4.897
Authors: Matthew R Trendowski; Omar El Charif; Paul C Dinh; Lois B Travis; M Eileen Dolan Journal: Clin Cancer Res Date: 2018-10-10 Impact factor: 12.531
Authors: Mitchell J Machiela; Casey L Dagnall; Anand Pathak; Jennifer T Loud; Stephen J Chanock; Mark H Greene; Katherine A McGlynn; Douglas R Stewart Journal: J Hum Genet Date: 2017-03-09 Impact factor: 3.172
Authors: Eleni Giannoulatou; Geoffrey J Maher; Zhihao Ding; Ad J M Gillis; Lambert C J Dorssers; Alexander Hoischen; Ewa Rajpert-De Meyts; Gilean McVean; Andrew O M Wilkie; Leendert H J Looijenga; Anne Goriely Journal: PLoS One Date: 2017-05-22 Impact factor: 3.240